Cost-effectiveness and budget impact of lumacaftor/ivacaftor in the treatment of cystic fibrosis

P Vadagam, KM Kamal, JR Covvey, V Giannetti… - Journal of Managed …, 2018 - jmcp.org
This article has been corrected. Please see J Manag Care Spec Pharm. 2019; 25 (2): 285-
86. BACKGROUND: Cystic fibrosis (CF) is a chronic, progressive, genetic disease affecting …